The chemical class of MIP-1α activators comprises a diverse set of compounds with distinct mechanisms for enhancing the expression of Macrophage Inflammatory Protein-1α (MIP-1α). These activators play pivotal roles in the regulation of immune responses and inflammatory processes. One prominent member of this class is Resolvin E1, which activates MIP-1α by modulating the NF-κB signaling pathway. Resolvin E1 exerts anti-inflammatory effects by inhibiting NF-κB activation, thereby upregulating MIP-1α expression. Another activator, Forskolin, stimulates MIP-1α production through the cAMP-PKA pathway. By activating adenylate cyclase, Forskolin increases intracellular cAMP levels, subsequently activating protein kinase A (PKA) and enhancing MIP-1α expression. The phorbol ester Phorbol 12-myristate 13-acetate (PMA) mimics diacylglycerol (DAG) and activates MIP-1α by modulating the PKC signaling pathway. PMA stimulates PKC, leading to downstream phosphorylation events that enhance MIP-1α expression.
Additionally, A23187 induces MIP-1α expression by increasing intracellular calcium levels. As an ionophore, A23187 promotes calcium influx, activating signaling cascades that enhance MIP-1α production. Dimethyl fumarate activates MIP-1α through the Nrf2-ARE pathway, upregulating Nrf2 and leading to the transcriptional activation of genes, including MIP-1α. TLR7/8 agonists, such as Imiquimod, activate MIP-1α through the MyD88-dependent signaling pathway. Binding to Toll-like receptors (TLRs) initiates a cascade that activates nuclear factor-kappa B (NF-κB), enhancing MIP-1α expression. Sodium butyrate activates MIP-1α by inhibiting histone deacetylases (HDACs). As an HDAC inhibitor, sodium butyrate enhances histone acetylation, promoting an open chromatin structure that facilitates MIP-1α gene transcription.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin stimulates MIP-1α production through the cAMP-PKA pathway. By activating adenylate cyclase, forskolin increases intracellular cAMP levels, subsequently activating protein kinase A (PKA) and enhancing MIP-1α expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates MIP-1α by modulating the PKC signaling pathway. It mimics diacylglycerol (DAG) and activates PKC, leading to the phosphorylation of downstream targets that enhance MIP-1α expression. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 induces MIP-1α expression by increasing intracellular calcium levels. This ionophore stimulates calcium influx, activating signaling cascades that enhance MIP-1α production. | ||||||
Dimethyl fumarate | 624-49-7 | sc-239774 | 25 g | $28.00 | 6 | |
Dimethyl fumarate activates MIP-1α through the Nrf2-ARE pathway. It upregulates nuclear factor erythroid 2-related factor 2 (Nrf2), leading to the transcriptional activation of antioxidant response element (ARE)-containing genes, including MIP-1α. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate activates MIP-1α by inhibiting histone deacetylases (HDACs). As an HDAC inhibitor, sodium butyrate enhances histone acetylation, promoting an open chromatin structure that facilitates MIP-1α gene transcription. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS activates MIP-1α through Toll-like receptor 4 (TLR4) signaling. Binding of LPS to TLR4 triggers the MyD88-dependent pathway, leading to the activation of NF-κB and subsequent upregulation of MIP-1α. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 activates MIP-1α through the cAMP-PKA pathway. By binding to its receptors, PGE2 increases intracellular cAMP levels, activating protein kinase A (PKA) and enhancing MIP-1α expression as part of the inflammatory response. | ||||||